Sotera Health Co (SHC) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
Total Revenue Chart for Sotera Health Co
Sotera Health Co (SHC) revenue for FY2025 was USD 1.2B, a 5.7% change from FY2024. Sotera Health Co's revenue grew from USD 746.1M in 2018 to USD 1.2B in 2025 (55.9% over 7 years). Earnings per share moved from USD -0.02 in 2018 to USD -0.83 in 2022. Revenue compound annual growth rate: 5-year CAGR of 7.3%.
Total Revenue (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $5.21B
- Implied Share Price
- $18.25
- Enterprise Value
- $7.13B
- Revenue (TTM)
- $1.22B
- EBITDA
- $576.58M
- Profit Margin
- 13.44%
- Trailing P/E
- 32.02
- Forward P/E
- 17.76
- Price/Book (MRQ)
- 7.84
- Price/Sales (TTM)
- 4.28
- EV/EBITDA
- 13.38
- EV/Revenue
- 5.86
- Dividend Yield
- —
- Book Value
- $2.33
- Free Cash Flow (FY2025)
- $149.18M
- Free Cash Flow Yield
- 2.86%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.